-
The pull of environmental affordances on selective attention
Dr. Zakaria Djebbara
-
EEG from bench to bedside: Conventional electrophysiological biomarkers and applied deep learning in Psychiatry
Sebastian Olbrich
-
Accelerated rTMS in mood disorders: a neurobiological point of view
Prof. Dr. Chris Baeken (MD, PhD)
-
Mechanisms Behind Neurotechnology-Assisted Rehabilitation: First Results from a Double-Blind Randomized Controlled Trial
Reinhold Scherer, PhD
-
Repetitive transcranial magnetic stimulation improves postoperative functional recovery in glioma patients: insights from Beijing Tiantan Hospital
Dr. Fan Xing on behalf of Prof. Jiang Tao
-
To be announced
John J. Foxe, PhD
-
Performance monitoring, post-error adjustments, and acetylcholine
Prof. Dr. med. habil. Markus Ullsperger
-
Assessing the impact of analytical choices on EEG results: Insights from the EEGManyPipelines project
Prof. Dr. Claudia Gianelli & Dr. Elena Cesnaite
-
To be announced
Prof. Dr. Elsa Kirchner
-
Contribution of new methods for combined EEG/MEG source analysis and optimized mc-TES to focal medication-resistant epilepsy
Prof. Dr. Carsten Wolters
John Rothwell is currently Emeritus Professor of Human Neurophysiology at UCL Queen Square Institute of Neurology and Fellow of the Academy of Medical Sciences. His work has provided the theoretical rationale and methodological developments underpinning the use of transcranial magnetic stimulation (TMS) as a novel therapy in stroke and depression. He has been a primary contributor to our understanding of how TMS interacts with ongoing brain activity, and has devised techniques to probe synaptic connections between brain areas that are now used as biomarkers in neurological disease and movement disorders. He has pioneered methods of repetitive stimulation that modulate synaptic plasticity, the basis of behavioural learning. This provides a unique opportunity to influence activity in human cerebral cortex and has opened up new therapeutic opportunities in neurology and psychiatry.
Most TMS devices produce a monophasic or biphasic standard pulse that was originally modelled on the narrow (50 ms) electrical pulses commonly used to stimulate large diameter fibres in peripheral nerve. The stimulators allow users to change the amplitude of the stimulus but not the waveform shape or polarity. However, new devices are appearing that allow much more flexible control of the pulse waveform as well as the ability to generate high frequency repetitive stimulation with monophasic as well as biphasic waveforms. Such innovations allow us to probe the characteristics of cortical neurons in much more detail, and improve targeting of different neural populations. The effects are evident in both the MEP and TEP (TMS evoked EEG potentials). For example, the relationship between threshold and pulse duration allows estimation of neural strength-duration time constants. These differ between different types of neuron and are changed by disease (ALS) and anti-epileptic drug therapy. The different time constants of excitatory and inhibitory neurons mean that waveform can be manipulated to improve, for example, short-interval intracortical inhibition (SICI). Repetitive monophasic stimulation can be more effective than the usual biphasic stimulation, and the same stimulator can be used for regular rTMS as well as quadrupulse TMS, which until now has required four separate TMS devices to be linked together. After 40 years of the same TMS, it is surely time to update our machines.